US FDA approves Lilly's breast cancer drug combo

The US FDA has approved Eli Lilly's drug combination to treat adults with a type of advanced breast cancer that ​has spread to other parts of the body, the drugmaker ‌said on Friday.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。